HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression
Abstract Background A number of effective antiviral agents for chronic hepatitis B are available worldwide, and these agents have exhibited satisfactory virologic suppression, but suboptimal responses still occur in some patients. We aimed to explore the contribution of long non-coding RNAs (lncRNAs...
Saved in:
| Main Authors: | Yang-Hsiang Lin, Ming-Wei Lai, Yu-De Chu, Kwang-Huei Lin, Chao-Wei Hsu, Rong-Nan Chien, Po-Heng Chuang, Chih-Lang Lin, Chau-Ting Yeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Cancer Cell International |
| Online Access: | https://doi.org/10.1186/s12935-025-03873-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Entecavir in clinical practice
by: Editorial Article
Published: (2018-08-01) -
Pseudogene: Relevant or Irrelevant?
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01) -
HBx promotes glomerular podocyte-induced immune cell responses
by: Luyan Bian, et al.
Published: (2024-12-01) -
Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01) -
Disrupting HBV Persistence: Genetic Engineering Approach to Break the Oncogenic HBx Gene
by: Saleha Resham, et al.
Published: (2025-08-01)